pluvicto
novartis europharm limited - lutetium (177lu) vipivotide tetraxetan - Новообразувания На Простатата, Кастраци-Упорит - Терапевтични радиофармацевтици - pluvicto in combination with androgen deprivation therapy (adt) with or without androgen receptor (ar) pathway inhibition is indicated for the treatment of adult patients with progressive prostate-specific membrane antigen (psma)-positive metastatic castration-resistant prostate cancer (mcrpc) who have been treated with ar pathway inhibition and taxane based chemotherapy.
neostomosan concentrate
ceva sante animale - transmix (тета - циперметрина); тетраметрин - разтвор за кожа - 5 g/100 ml; 0, 5 g/100 ml - коне, котки, кучета